Sdox, a H2S releasing anthracycline, with a safer profile than doxorubicin toward vasculature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sdox, a H2S releasing anthracycline, with a safer profile than doxorubicin toward vasculature

Published:2022-04 Issue: Volume:143 Page:106969
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Durante Miriam,Frosini Maria,Chiaino Elda,Fusi Fabio,Gamberucci Alessandra,Gorelli Beatrice,Chegaev Konstantin,Riganti Chiara,Saponara Simona

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference37 articles.

1. Preventing and treating anthracycline cardiotoxicity: new insights;Sawicki;Annu. Rev. Pharmacol. Toxicol.,2021

2. The multi-factorial nature of clinical multidrug resistance in cancer;Assaraf;Drug Resist. Updat.,2019

3. H2S-donating doxorubicins may overcome cardiotoxicity and multidrug resistance;Chegaev;J. Med. Chem.,2016

4. Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma;Buondonno;Cell. Mol. Life Sci.,2019

5. New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations;Bigagli;Investig. New Drugs,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydrogen sulfide: Recent development of its dual donors and hybrid drugs;British Journal of Pharmacology;2023-09

2. In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists;Journal of Medicinal Chemistry;2023-05-16

3. H2S Donors with Cytoprotective Effects in Models of MI/R Injury and Chemotherapy-Induced Cardiotoxicity;Antioxidants;2023-03-05

4. Naked and Decorated Nanoparticles Containing H2S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells;International Journal of Molecular Sciences;2022-09-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3